US Patent 11504421 Alphavirus neoantigen vectors
Patent 11504421 was granted and assigned to Gritstone Bio on November, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 30 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 27 Mar, 2023
Golden AI
Infobox
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115044210
Date of Patent
November 22, 2022
0Patent Application Number
166123520
Date Filed
May 8, 2018
0Patent Citations
Patent Primary Examiner
Edits on 25 Nov, 2022
Golden AI
Edits made to:
Infobox (+14 properties)
Article (+242 characters)
US Patent 11504421 Alphavirus neoantigen vectors
Article
Disclosed herein are alphavirus vectors that include neoantigen-encoding nucleic acid sequences derived from a tumor of a subject. Also disclosed are nucleotides, cells, and methods associated with the vectors including their use as vaccines.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115044210
Date of Patent
November 22, 2022
0Patent Application Number
166123520
Date Filed
May 8, 2018
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11504421 Alphavirus neoantigen vectors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.